Exhibit 99.1

Allegro MicroSystems Reports First Quarter 2026 Results

Sales Increased 22% Year-Over-Year to $203 Million

Manchester, NH, July 31, 2025 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its first quarter ended June 27, 2025.

“We delivered strong first quarter results, with sales of over $203 million, up 22% year-over-year, and led by growth in both e-Mobility and Industrial and Other, increasing 31% and 50% year-over-year, respectively. Non-GAAP EPS was $0.09, increasing nearly 3x year-over-year, demonstrating the significant operating leverage in our business model,” said Mike Doogue, President and CEO of Allegro. “In addition to this strong financial performance, we are encouraged by the positive momentum we are seeing across the business, including continued strong bookings, increasing backlog, a return to growth in automotive and industrial end markets, and strong design win activity in our strategic focus areas.”

“We also continue to focus on cash flow, improving our gross margin and return on invested capital," said Derek D’Antilio, Executive Vice President and CFO of Allegro. "During the first quarter, our free cash flow was $51 million, or 25% of sales. In the first quarter, we made voluntary debt repayments of $35 million in addition to $105 million in voluntary debt repayments in the prior fiscal year.”

 

In thousands, except per share data

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Net Sales*

 

 

 

 

 

 

 

 

 

Automotive

 

$

144,264

 

 

$

139,494

 

 

$

127,394

 

Industrial and other

 

 

59,141

 

 

 

53,330

 

 

 

39,525

 

Total net sales

 

$

203,405

 

 

$

192,824

 

 

$

166,919

 

GAAP Financial Measures

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

44.9

%

 

 

41.4

%

 

 

44.8

%

Operating margin %

 

 

(1.3

)%

 

 

(6.8

)%

 

 

(6.4

)%

Diluted EPS

 

$

(0.07

)

 

$

(0.08

)

 

$

(0.09

)

Non-GAAP Financial Measures

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

48.2

%

 

 

45.6

%

 

 

48.8

%

Operating margin %

 

 

11.1

%

 

 

9.0

%

 

 

6.0

%

Diluted EPS

 

$

0.09

 

 

$

0.06

 

 

$

0.03

 

*During the preparation of the fourth quarter fiscal year 2025 interim condensed consolidated financial statements, the Company identified an immaterial misclassification of net sales by application in the table above, whereby customer returns and sales allowances were incorrectly classified by application between Automotive and Industrial and Other in the prior periods presented above. There was no impact to previously reported total net sales or net income in any of the periods noted above. Net sales by application in the prior periods presented in the table above have been corrected and are presented on the same basis as the first quarter of fiscal year 2026.

Business Outlook

For the second quarter of fiscal year 2026 ending September 26, 2025, the Company expects total net sales to be in the range of
$205 million to $215 million. At the midpoint of this range, it implies a net sales growth of 12% year-over-year.

The Company also estimates the following results on a non-GAAP basis:

Gross Margin is expected to be between 48% and 50%,
Operating expenses are expected to be approximately $73 million,
Interest expense of approximately $5 million inclusive of an expected additional voluntary debt repayment of $25 million today, and
Diluted Earnings per Share is expected to be between $0.10 and $0.14, up 50% year-over-year at the midpoint.

 

Allegro has not provided a reconciliation of its second fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Interest Expense, and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.


Earnings Webcast

A webcast will be held on Thursday, July 31, 2025 at 8:30 a.m., Eastern Time. Michael C. Doogue, President and Chief Executive Officer, and Derek P. D’Antilio, Executive Vice President and Chief Financial Officer, will discuss Allegro’s business and financial results.

The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems, Inc. is leveraging more than three decades of expertise in magnetic sensing and power ICs, to propel automotive, clean energy and industrial automation forward with solutions that enhance efficiency, performance and sustainability. Allegro’s commitment to quality drives transformation across industries, reinforcing our status as a pioneer in “automotive grade” technology and a partner in our customers' success. For additional information, please visit https://www.allegromicro.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 28, 2025, as any such factors may be updated from time to time in our Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission (the “SEC”). These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; any failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix, customer mix or channel mix, which could negatively impact our gross margin; the cyclical nature of the semiconductor industry, including the analog segment in which we compete; any downturn or disruption in the automotive market or industry; our ability to successfully integrate the acquisition of other companies or technologies and products into our business; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results and meet the expectations of investors; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; events beyond our control impacting us, our key suppliers or our manufacturing partners; our ability to develop new product features or new products in a timely and cost-effective manner; our dependence on growth in the end markets that use our products and the impact that slowdowns in such growth could have on our financial results; the loss of one or more significant customers; our ability to identify, enter and expand in new markets, and to generate returns on such investments; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulations and other legal obligations, including export/trade control, privacy, data protection, information security, cybersecurity, consumer protection, environmental and occupational health and safety, antitrust, anti-corruption and anti-bribery, product safety, environmental protection, employment matters and tax; the risk of unsolicited acquisition proposals; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to retain key and highly skilled personnel; the impact of restructuring activities on our business and operating


results; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or confidential information or those of our third-party service providers; any failure to maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; the risks presented by climate change; the risks related to ESG matters; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the SEC rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their most directly comparable GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(Unaudited)

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

June 28, 2024

 

Net sales

 

$

203,405

 

 

$

166,919

 

Cost of goods sold

 

 

112,103

 

 

 

92,148

 

Gross profit

 

 

91,302

 

 

 

74,771

 

Operating expenses:

 

 

 

 

 

 

Research and development

 

 

46,500

 

 

 

45,204

 

Selling, general and administrative

 

 

47,542

 

 

 

40,197

 

Total operating expenses

 

 

94,042

 

 

 

85,401

 

Operating loss

 

 

(2,740

)

 

 

(10,630

)

Interest and other expense

 

 

(7,253

)

 

 

(5,943

)

Loss before income taxes

 

 

(9,993

)

 

 

(16,573

)

Income tax provision

 

 

3,169

 

 

 

1,040

 

Net loss

 

 

(13,162

)

 

 

(17,613

)

Net income attributable to non-controlling interests

 

 

65

 

 

 

62

 

Net loss attributable to Allegro MicroSystems, Inc.

 

$

(13,227

)

 

$

(17,675

)

Net loss per common share attributable to Allegro MicroSystems, Inc.:

 

 

 

 

 

 

Basic

 

$

(0.07

)

 

$

(0.09

)

Diluted

 

$

(0.07

)

 

$

(0.09

)

Weighted average shares outstanding:

 

 

 

 

 

 

Basic

 

 

184,587,027

 

 

 

193,465,708

 

Diluted

 

 

184,587,027

 

 

 

193,465,708

 

 

Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company’s unaudited condensed consolidated statements of operations:

 

Three-Month Period Ended

 

 

Change

 

 

June 27, 2025

 

 

June 28, 2024

 

 

Amount

 

 

%

 

 

(Dollars in thousands)

 

Automotive

 

$

144,264

 

 

$

127,394

 

 

$

16,870

 

 

 

13

%

Industrial and other

 

 

59,141

 

 

 

39,525

 

 

 

19,616

 

 

 

50

%

Total net sales

 

$

203,405

 

 

$

166,919

 

 

$

36,486

 

 

 

22

%

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

June 27,

 

 

March 28,

 

 

2025
(Unaudited)

 

 

2025

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

129,106

 

 

$

121,334

 

Restricted cash

 

 

10,273

 

 

 

9,773

 

Trade accounts receivable, net

 

 

89,379

 

 

 

84,598

 

Inventories

 

 

173,796

 

 

 

183,914

 

Prepaid income taxes

 

 

968

 

 

 

36,662

 

Prepaid expenses and other current assets

 

 

27,054

 

 

 

30,247

 

Assets held for sale

 

 

16,508

 

 

 

16,508

 

Total current assets

 

 

447,084

 

 

 

483,036

 

Property, plant and equipment, net

 

 

305,195

 

 

 

302,919

 

Deferred income tax assets

 

 

73,839

 

 

 

68,528

 

Goodwill

 

 

203,328

 

 

 

202,475

 

Intangible assets, net

 

 

256,414

 

 

 

262,115

 

Equity investment in related party

 

 

30,874

 

 

 

31,695

 

Other assets

 

 

72,474

 

 

 

70,193

 

Total assets

 

$

1,389,208

 

 

$

1,420,961

 

Liabilities, Non-Controlling Interest and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Trade accounts payable

 

$

45,609

 

 

$

38,733

 

Amounts due to related party

 

 

2,902

 

 

 

6,535

 

Accrued expenses and other current liabilities

 

 

70,639

 

 

 

65,570

 

Current portion of long-term debt

 

 

1,535

 

 

 

1,423

 

Total current liabilities

 

 

120,685

 

 

 

112,261

 

Long-term debt

 

 

310,790

 

 

 

344,703

 

Other long-term liabilities

 

 

33,476

 

 

 

32,897

 

Total liabilities

 

 

464,951

 

 

 

489,861

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

1,849

 

 

 

1,843

 

Additional paid-in capital

 

 

1,013,795

 

 

 

1,012,055

 

Accumulated deficit

 

 

(66,818

)

 

 

(53,591

)

Accumulated other comprehensive loss

 

 

(26,173

)

 

 

(30,752

)

Equity attributable to Allegro MicroSystems, Inc.

 

 

922,653

 

 

 

929,555

 

Non-controlling interest

 

 

1,604

 

 

 

1,545

 

Total stockholders’ equity

 

 

924,257

 

 

 

931,100

 

Total liabilities, non-controlling interest and stockholders’ equity

 

$

1,389,208

 

 

$

1,420,961

 

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

June 28, 2024

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(13,162

)

 

$

(17,613

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

16,216

 

 

 

16,458

 

Amortization of deferred financing costs

 

 

933

 

 

 

781

 

Deferred income taxes

 

 

(5,061

)

 

 

(4,999

)

Stock-based compensation

 

 

10,762

 

 

 

10,118

 

Provisions for inventory and expected credit losses

 

 

3,450

 

 

 

2,377

 

Other non-cash reconciling items

 

 

(58

)

 

 

14

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Trade accounts receivable

 

 

(5,332

)

 

 

55,134

 

Inventories

 

 

7,233

 

 

 

(15,986

)

Prepaid expenses and other assets

 

 

35,965

 

 

 

(1,715

)

Trade accounts payable

 

 

6,281

 

 

 

200

 

Due to and from related parties

 

 

(3,633

)

 

 

3,437

 

Accrued expenses and other current and long-term liabilities

 

 

8,024

 

 

 

(14,010

)

Net cash provided by operating activities

 

 

61,618

 

 

 

34,196

 

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(10,600

)

 

 

(10,977

)

Net cash used in investing activities

 

 

(10,600

)

 

 

(10,977

)

Cash flows from financing activities:

 

 

 

 

 

 

Repayment of term loan

 

 

(35,000

)

 

 

(50,000

)

Finance lease payments

 

 

(202

)

 

 

(145

)

Receipts on related party notes receivable

 

 

 

 

 

938

 

Payments for taxes related to net share settlement of equity awards

 

 

(8,988

)

 

 

(11,171

)

Net cash used in by financing activities

 

 

(44,190

)

 

 

(60,378

)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

 

1,444

 

 

 

(825

)

Net increase (decrease) in cash and cash equivalents and restricted cash

 

 

8,272

 

 

 

(37,984

)

Cash and cash equivalents and restricted cash at beginning of period

 

 

131,107

 

 

 

222,161

 

Cash and cash equivalents and restricted cash at end of period:

 

$

139,379

 

 

$

184,177

 

 


Non-GAAP Financial Measures

In addition to the measures presented in our condensed consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision, non-GAAP Effective Tax Rate, non-GAAP Net Income Attributable to Allegro MicroSystems, Inc, non-GAAP Basic and Diluted Earnings per Share, non-GAAP Free Cash Flow, and non-GAAP Free Cash Flow as a percentage of net sales (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Income Tax Provision, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Income Tax Provision across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures, such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges, such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These Non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related-party activities and other non-operational costs.

Non-GAAP Income Tax Provision

In calculating non-GAAP Income Tax Provision, we have added back the following to GAAP Income Tax Provision:

Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described below and elimination of discrete tax adjustments.

 

Reconciliation of Non-GAAP Gross Profit and Non-GAAP Gross Margin

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

(Dollars in thousands)

 

GAAP Gross Profit

 

$

91,302

 

 

$

79,879

 

 

$

74,771

 

GAAP Gross Margin (% of net sales)

 

 

44.9

%

 

 

41.4

%

 

 

44.8

%

 

 

 

 

 

 

 

 

 

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

 

 

 

 

 

 

(1

)

Purchased intangible amortization

 

 

5,089

 

 

 

4,957

 

 

 

4,875

 

Restructuring costs

 

 

705

 

 

 

2,350

 

 

 

1,200

 

Stock-based compensation

 

 

888

 

 

 

697

 

 

 

561

 

Total Non-GAAP Adjustments

 

$

6,682

 

 

$

8,004

 

 

$

6,635

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Gross Profit

 

$

97,984

 

 

$

87,883

 

 

$

81,406

 

Non-GAAP Gross Margin (% of net sales)

 

 

48.2

%

 

 

45.6

%

 

 

48.8

%

 


 

Reconciliation of Non-GAAP Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

(Dollars in thousands)

 

GAAP Operating Expenses

 

$

94,042

 

 

$

93,077

 

 

$

85,401

 

 

 

 

 

 

 

 

 

 

 

Research and Development Expenses

 

 

 

 

 

 

 

 

 

GAAP Research and Development Expenses

 

 

46,500

 

 

 

47,618

 

 

 

45,204

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

 

 

 

3

 

 

 

1,029

 

Purchased intangible amortization

 

 

3

 

 

 

 

 

 

 

Restructuring costs

 

 

1,131

 

 

 

4,429

 

 

 

169

 

Stock-based compensation

 

 

2,911

 

 

 

3,406

 

 

 

3,735

 

Other costs(1)

 

 

35

 

 

 

 

 

 

 

Non-GAAP Research and Development Expenses

 

 

42,420

 

 

 

39,780

 

 

 

40,271

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

 

 

 

 

 

 

 

GAAP Selling, General and Administrative Expenses

 

 

47,542

 

 

 

45,459

 

 

 

40,197

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

130

 

 

 

116

 

 

 

814

 

Purchased intangible amortization

 

 

535

 

 

 

535

 

 

 

535

 

Restructuring costs

 

 

1,184

 

 

 

1,656

 

 

 

1,045

 

Stock-based compensation

 

 

6,963

 

 

 

5,513

 

 

 

5,822

 

Other costs(1)

 

 

5,838

 

 

 

6,921

 

 

 

811

 

Non-GAAP Selling, General and Administrative Expenses

 

 

32,892

 

 

 

30,718

 

 

 

31,170

 

 

 

 

 

 

 

 

 

 

 

Total Non-GAAP Adjustments

 

 

18,730

 

 

 

22,579

 

 

 

13,960

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Expenses

 

$

75,312

 

 

$

70,498

 

 

$

71,441

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 

 

Reconciliation of Non-GAAP Operating Income and Non-GAAP Operating Margin

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

(Dollars in thousands)

 

GAAP Operating Loss

 

$

(2,740

)

 

$

(13,198

)

 

$

(10,630

)

GAAP Operating Margin (% of net sales)

 

 

(1.3

)%

 

 

(6.8

)%

 

 

(6.4

)%

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

130

 

 

 

119

 

 

 

1,842

 

Purchased intangible amortization

 

 

5,627

 

 

 

5,492

 

 

 

5,410

 

Restructuring costs

 

 

3,020

 

 

 

8,435

 

 

 

2,414

 

Stock-based compensation

 

 

10,762

 

 

 

9,616

 

 

 

10,118

 

Other costs(1)

 

 

5,873

 

 

 

6,921

 

 

 

811

 

Total Non-GAAP Adjustments

 

$

25,412

 

 

$

30,583

 

 

$

20,595

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Income

 

$

22,672

 

 

$

17,385

 

 

$

9,965

 

Non-GAAP Operating Margin (% of net sales)

 

 

11.1

%

 

 

9.0

%

 

 

6.0

%

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 


Reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

(Dollars in thousands)

 

GAAP Net Loss

 

$

(13,162

)

 

$

(14,738

)

 

$

(17,613

)

GAAP Net Loss Margin (% of net sales)

 

 

(6.5

)%

 

 

(7.6

)%

 

 

(10.6

)%

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

6,359

 

 

 

6,874

 

 

 

5,377

 

Interest income

 

 

(234

)

 

 

(222

)

 

 

(494

)

Income tax provision (benefit)

 

 

3,169

 

 

 

(3,700

)

 

 

1,040

 

Depreciation & amortization

 

 

16,216

 

 

 

15,924

 

 

 

16,458

 

EBITDA

 

$

12,348

 

 

$

4,138

 

 

$

4,768

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

130

 

 

 

119

 

 

 

1,842

 

Restructuring costs

 

 

2,824

 

 

 

8,277

 

 

 

2,414

 

Stock-based compensation

 

 

10,762

 

 

 

9,616

 

 

 

10,118

 

Other costs(1)

 

 

7,304

 

 

 

6,301

 

 

 

2,807

 

Adjusted EBITDA

 

$

33,368

 

 

$

28,451

 

 

$

21,949

 

Adjusted EBITDA Margin (% of net sales)

 

 

16.4

%

 

 

14.8

%

 

 

13.1

%

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 

Reconciliation of Non-GAAP Profit before Tax

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

(Dollars in thousands)

 

GAAP Loss before Income Taxes

 

$

(9,993

)

 

$

(18,438

)

 

$

(16,573

)

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

130

 

 

 

119

 

 

 

1,842

 

Transaction-related interest

 

 

860

 

 

 

272

 

 

 

709

 

Purchased intangible amortization

 

 

5,627

 

 

 

5,492

 

 

 

5,410

 

Restructuring costs

 

 

3,020

 

 

 

8,482

 

 

 

2,414

 

Stock-based compensation

 

 

10,762

 

 

 

9,616

 

 

 

10,118

 

Other costs(1)

 

 

7,304

 

 

 

6,689

 

 

 

2,807

 

Total Non-GAAP Adjustments

 

$

27,703

 

 

$

30,670

 

 

$

23,300

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Profit before Tax

 

$

17,710

 

 

$

12,232

 

 

$

6,727

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 

Reconciliation of Non-GAAP Income Tax Provision and Non-GAAP Effective Tax Rate

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

(Dollars in thousands)

 

GAAP Income Tax Provision (Benefit)

 

$

3,169

 

 

$

(3,700

)

 

$

1,040

 

GAAP effective tax rate

 

 

(31.7

)%

 

 

20.1

%

 

 

(6.3

)%

 

 

 

 

 

 

 

 

 

 

Tax effect of adjustments to GAAP results

 

 

(1,483

)

 

 

4,126

 

 

 

(395

)

 

 

 

 

 

 

 

 

 

 

Non-GAAP Income Tax Provision

 

$

1,686

 

 

$

426

 

 

$

645

 

Non-GAAP effective tax rate

 

 

9.5

%

 

 

3.5

%

 

 

9.6

%

 

 


Reconciliation of Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. and Non-GAAP Earnings per Share

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

(Dollars in thousands)

 

GAAP Net Loss Attributable to Allegro MicroSystems, Inc.(1)

 

$

(13,227

)

 

$

(14,800

)

 

$

(17,675

)

GAAP Basic weighted average common shares

 

 

184,587,027

 

 

 

184,169,928

 

 

 

193,465,708

 

GAAP Diluted weighted average common shares

 

 

184,587,027

 

 

 

184,169,928

 

 

 

193,465,708

 

GAAP Basic Loss per Share

 

$

(0.07

)

 

$

(0.08

)

 

$

(0.09

)

GAAP Diluted Loss per Share

 

$

(0.07

)

 

$

(0.08

)

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

130

 

 

 

119

 

 

 

1,842

 

Transaction-related interest

 

 

860

 

 

 

272

 

 

 

709

 

Purchased intangible amortization

 

 

5,627

 

 

 

5,492

 

 

 

5,410

 

Restructuring costs

 

 

3,020

 

 

 

8,482

 

 

 

2,414

 

Stock-based compensation

 

 

10,762

 

 

 

9,616

 

 

 

10,118

 

Other costs(2)

 

 

7,304

 

 

 

6,689

 

 

 

2,807

 

Total Non-GAAP Adjustments

 

 

27,703

 

 

 

30,670

 

 

 

23,300

 

Tax effect of adjustments to GAAP results(3)

 

 

1,483

 

 

 

(4,126

)

 

 

395

 

Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc.

 

$

15,959

 

 

$

11,744

 

 

$

6,020

 

Basic weighted average common shares

 

 

184,587,027

 

 

 

184,169,928

 

 

 

193,465,708

 

Diluted weighted average common shares

 

 

185,416,258

 

 

 

185,247,919

 

 

 

194,705,716

 

Non-GAAP Basic Earnings per Share

 

$

0.09

 

 

$

0.06

 

 

$

0.03

 

Non-GAAP Diluted Earnings per Share

 

$

0.09

 

 

$

0.06

 

 

$

0.03

 

 

 

 

 

 

 

 

 

 

 

(1) GAAP Net Loss Attributable to Allegro MicroSystems, Inc. represents GAAP Net Loss adjusted for Net Income Attributable to non-controlling interests.

 

(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consists of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, income (loss) in earnings of equity investments, and unrealized losses (gains) on investments.

 

(3) To calculate the tax effect of adjustments to GAAP results, the Company considers each Non-GAAP adjustment by tax jurisdiction and reverses all discrete items to calculate an annual non-GAAP effective tax rate (“NG ETR”). This NG ETR is then applied to Non-GAAP Profit Before Tax to arrive at the tax effect of adjustments to GAAP results.

 

 

 

Reconciliation of Non-GAAP Free Cash Flow and Non-GAAP Free Cash Flow as Percentage of Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 27, 2025

 

 

March 28, 2025

 

 

June 28, 2024

 

 

(Dollars in thousands)

 

GAAP Operating Cash Flow

 

$

61,618

 

 

$

20,353

 

 

$

34,196

 

GAAP Operating Cash Flow (% of net sales)

 

 

30.3

%

 

 

10.6

%

 

 

20.5

%

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(10,600

)

 

 

(5,391

)

 

 

(10,977

)

 

 

 

 

 

 

 

 

 

 

Non-GAAP Free Cash Flow

 

$

51,018

 

 

$

14,962

 

 

$

23,219

 

Non-GAAP Free Cash Flow (% of net sales)

 

 

25.1

%

 

 

7.8

%

 

 

13.9

%

Investor Contact:

Jalene Hoover

VP of Investor Relations & Corporate Communications

+1 (512) 751-6526

jhoover@allegromicro.com